Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In situ detection of individual classical MHC-I gene products in cancer.
Gonzalez-Ericsson PI, Opalenik SR, Sanchez V, Palubinsky A, Hanna A, Sun X, Ocampo AA, Garcia G, Maldonado L, Morante Z, Vidaurre T, Valencia G, Gomez HL, Sanders ME, Kennedy LC, Phillips E, Balko JM. Gonzalez-Ericsson PI, et al. Among authors: morante z. Cancer Immunol Res. 2025 Jan 13. doi: 10.1158/2326-6066.CIR-24-1003. Online ahead of print. Cancer Immunol Res. 2025. PMID: 39804685
Brain Metastasis in Triple-Negative Breast Cancer.
Bustamante E, Casas F, Luque R, Piedra L, Barros-Sevillano S, Chambergo-Michilot D, Torres-Roman JS, Narvaez-Rojas A, Morante Z, Enriquez-Vera D, Desai A, Razuri C, De la Cruz-Ku G, Araujo J. Bustamante E, et al. Among authors: morante z. Breast J. 2024 Sep 30;2024:8816102. doi: 10.1155/2024/8816102. eCollection 2024. Breast J. 2024. PMID: 39742363 Free PMC article.
First-Line (1L) Treatment Decision Patterns and Survival of Hormone Receptor (HR)-Positive/HER2-Negative Advanced Breast Cancer (ABC) Patients in a Latin American (LATAM) Public Institution.
Valencia G, Rioja P, Chirito M, Peralta O, Sánchez J, Rabanal C, Mantilla R, Morante Z, Fuentes H, Castaneda C, Vidaurre T, Pacheco C, Neciosup S, Gomez HL. Valencia G, et al. Among authors: morante z. Curr Oncol. 2024 Dec 9;31(12):7890-7902. doi: 10.3390/curroncol31120581. Curr Oncol. 2024. PMID: 39727704 Free PMC article.
Evaluation of multiple breast cancer polygenic risk score panels in women of Latin American heritage.
Huang X, Lott PC, Hu D, Zavala VA, Jamal ZN, Vidaurre T, Casavilca-Zambrano S, Navarro Vásquez J, Castañeda CA, Valencia G, Morante Z, Calderón M, Abugattas JE, Fuentes HA, Liendo-Picoaga R, Cotrina JM, Neciosup SP, Rioja Viera P, Salinas LA, Galvez-Nino M, Huntsman S, Sanchez SE, Williams MA, Gelaye B, Estrada-Florez AP, Polanco-Echeverry G, Echeverry M, Velez A, Carmona-Valencia JA, Bohorquez-Lozano ME, Torres J, Cruz M, Ho WK, Teo SH, Tai MC, John EM, Haiman CA, Conti DV, Chen F, Torres-Mejía G, Kushi LH, Neuhausen SL, Ziv E, Carvajal-Carmona LG, Fejerman L. Huang X, et al. Among authors: morante z. Cancer Epidemiol Biomarkers Prev. 2024 Dec 3. doi: 10.1158/1055-9965.EPI-24-1247. Online ahead of print. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 39625644
Impact on Survival with Immunotherapy and Evaluation of Biomarkers in Peruvian Patients with Advanced Melanoma.
Valencia G, Roque K, Rioja P, Huamán JA, Colomo V, Sánchez J, Calle C, Mantilla R, Morante Z, Fuentes H, Vidaurre T, Neciosup S, De Mello RA, Gómez HL, Fernández-Díaz AB, Berrocal A, Castaneda C. Valencia G, et al. Among authors: morante z. Onco Targets Ther. 2024 Nov 2;17:871-886. doi: 10.2147/OTT.S483753. eCollection 2024. Onco Targets Ther. 2024. PMID: 39507408 Free PMC article.
Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2-Positive Breast Cancer.
Otoya I, Valdiviezo N, Morante Z, Calle C, Ferreyra Y, Huarcaya-Chombo N, Polo-Mendoza G, Castañeda C, Vidaurre T, Neciosup SP, Calderón MJ, Gomez HL. Otoya I, et al. Among authors: morante z. Int J Breast Cancer. 2024 Jun 22;2024:9551710. doi: 10.1155/2024/9551710. eCollection 2024. Int J Breast Cancer. 2024. PMID: 38962673 Free PMC article.
Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience.
Piedra-Delgado L, Chambergo-Michilot D, Morante Z, Fairen C, Jerves-Coello F, Luque-Benavides R, Casas F, Bustamante E, Razuri-Bustamante C, Torres-Roman JS, Fuentes H, Gomez H, Narvaez-Rojas A, De la Cruz-Ku G, Araujo J. Piedra-Delgado L, et al. Among authors: morante z. PLoS One. 2024 Feb 1;19(2):e0293833. doi: 10.1371/journal.pone.0293833. eCollection 2024. PLoS One. 2024. PMID: 38300959 Free PMC article.
Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in triple-negative breast cancer.
Morante Z, Ferreyra Y, Pinto JA, Valdivieso N, Castañeda C, Vidaurre T, Valencia G, Rioja P, Fuentes H, Cotrina JM, Neciosup S, Gomez HL. Morante Z, et al. Front Oncol. 2023 Nov 6;13:1193927. doi: 10.3389/fonc.2023.1193927. eCollection 2023. Front Oncol. 2023. PMID: 38023174 Free PMC article.
33 results